BMS-192364 structure
|
Common Name | BMS-192364 | ||
|---|---|---|---|---|
| CAS Number | 202822-21-7 | Molecular Weight | 355.70 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H9ClF3N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BMS-192364BMS-192364 is targeting the Gα-RGS interaction to produce an inactive Gα-RGS complex. BMS-192364 reduces urinary bladder contraction and exert RGS-agonist properties by increasing the action of GAPs on Gq proteins. BMS-192364 inhibits calcium flux[1][2][3]. |
| Name | 2-(5-chloro-2-hydroxyphenyl)-5-[4-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-one |
|---|---|
| Synonym | More Synonyms |
| Description | BMS-192364 is targeting the Gα-RGS interaction to produce an inactive Gα-RGS complex. BMS-192364 reduces urinary bladder contraction and exert RGS-agonist properties by increasing the action of GAPs on Gq proteins. BMS-192364 inhibits calcium flux[1][2][3]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C15H9ClF3N3O2 |
|---|---|
| Molecular Weight | 355.70 |
| Exact Mass | 355.03400 |
| PSA | 70.91000 |
| LogP | 3.60540 |
| unii-1nc8d8p7qf |